A real-world analysis of anamorelin in patients with advanced cancer; A Multicenter, Retrospective Cohort Study

Not Applicable

Completed

• Conditions: cancer cachexia

• Registration Number: JPRN-UMIN000051550
• Lead Sponsor: Hokkaido Gastrointestinal Cancer Study Group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-10
• Last Update Posted: 17 October 2023
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 176

Inclusion Criteria

Not provided

Exclusion Criteria

1)Participation in the clinical trial is determined as unsuitable.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in FAACT appetite-related scores before and after starting anamorelin hydrochloride

Secondary Outcome Measures

Name	Time	Method
1)Change in body weight (kg) before and after starting anamorelin hydrochloride 2)Change in ECOG PS after anamorelin hydrochloride initiation 3)Frequency of anamorelin-related adverse events 4)Change in FAACT appetite-related score after anamorelin hydrochloride initiation by patient's background 5)Weight change after anamorelin hydrochloride initiation by patient's backgrounds 6)Change in ECOG PS after starting anamorelin hydrochloride by patient's backgrounds 7)Frequency of adverse events attributable to anamorelin hydrochloride by patient's backgrounds